Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies
Clinical trial NCT04370704 · COMPLETED
Trial details
- NCT number
- NCT04370704
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2025-08-25
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.